You have 9 free searches left this month | for more free features.

Condition

HIV Infections (2)

Human Immunodeficiency Virus (1)

Infection, Human Immunodeficiency Virus (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

ViiV Healthcare (2)

Centre for the AIDS Programme of Research in South Africa (1)

Collaborator

GlaxoSmithKline (1)

ViiV Healthcare (1)

Intervention

cabotegravir (3)

placebo (1)

rhuph20 (1)

rifabutin (1)

standard of care (soc) (1)

vh3810109 (1)

Study Documents

Intervention Type

drug (3)

biological (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

cabotegravir

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))

Not yet recruiting

HIV Infections

VH3810109
+3 more

Birmingham, Alabama
+42 more

Aug 9, 2023

Infection, Human Immunodeficiency Virus, HIV Trial in Cambridge (Cabotegravir, Rifabutin)

Completed

Has Results

Infection, Human Immunodeficiency Virus
HIV Infections

Cabotegravir
Rifabutin

Cambridge, United Kingdom

GSK Investigational Site

Aug 27, 2020

Human Immunodeficiency Virus Trial in Durban, Mafakatini (cabotegravir, Placebo)

Withdrawn

Human Immunodeficiency Virus

cabotegravir
Placebo

Durban, KwaZulu-Natal, South Africa
+1 more

Nov 4, 2015